KG
Kapil Ganeshmal Sonigara
About Kapil Ganeshmal Sonigara
Data last updated:
Kapil Ganeshmal Sonigara has 20 years in corporate governance. Holds Director role. Currently with 1 company, including Zyphar's Pharmaceutics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Zyphar's Pharmaceutics Private Limited at ₹222 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Zyphar's Pharmaceutics Private Limited U24231PN2006PTC022042 | Director | 17 Feb 2006 | 2006 | ₹222 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kapil Ganeshmal Sonigara
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kapil Ganeshmal Sonigara
Kapil Ganeshmal Sonigara has 20 years in corporate governance. Holds Director role. Currently with 1 company, including Zyphar's Pharmaceutics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Zyphar's Pharmaceutics Private Limited at ₹222 Cr (FY 2025).
Kapil Ganeshmal Sonigara is associated with 1 company as Director, including Zyphar's Pharmaceutics Private Limited (₹222 Cr).
Kapil Ganeshmal Sonigara has expertise in General Business.
Kapil Ganeshmal Sonigara has 20 years in corporate governance.
By reported revenue, the largest current company of Kapil Ganeshmal Sonigara is Zyphar's Pharmaceutics Private Limited, with revenue of ₹222 Cr (FY 2025).
Kapil Ganeshmal Sonigara currently holds positions at 1 company: Zyphar's Pharmaceutics Private Limited (₹222 Cr).